P

Porton Pharma Solutions Ltd
SZSE:300363

Watchlist Manager
Porton Pharma Solutions Ltd
SZSE:300363
Watchlist
Price: 25.86 CNY -2.23%
Market Cap: 14.1B CNY

Intrinsic Value

The intrinsic value of one Porton Pharma Solutions Ltd stock under the Base Case scenario is 18.69 CNY. Compared to the current market price of 25.86 CNY, Porton Pharma Solutions Ltd is Overvalued by 28%.

Intrinsic Value
18.69 CNY
Overvaluation 28%
Intrinsic Value
Price
P
Worst Case
Base Case
Best Case

Valuation History
Porton Pharma Solutions Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about Porton Pharma Solutions Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Porton Pharma Solutions Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Porton Pharma Solutions Ltd.

Explain Valuation
Compare Porton Pharma Solutions Ltd to
Custom
Choose any stock to compare

Fundamental Analysis

Profitability Score
Profitability Due Diligence

Loading...
Loading...
Loading...
Loading...
Profitability
Score

Solvency Score
Solvency Due Diligence

Loading...
Loading...
Loading...
Loading...
Solvency
Score
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Porton Pharma Solutions Ltd?
Bearish
Neutral
Bullish
Efficiency

Free Cash Flow Analysis
Porton Pharma Solutions Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Wall St
Price Targets

Price Targets Summary
Porton Pharma Solutions Ltd

Wall Street analysts forecast Porton Pharma Solutions Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Porton Pharma Solutions Ltd is 30.6 CNY with a low forecast of 30.3 CNY and a high forecast of 31.5 CNY.

Lowest
Price Target
30.3 CNY
17% Upside
Average
Price Target
30.6 CNY
18% Upside
Highest
Price Target
31.5 CNY
22% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Porton Pharma Solutions Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Porton Pharma Solutions Ltd stock?

The intrinsic value of one Porton Pharma Solutions Ltd stock under the Base Case scenario is 18.69 CNY.

Is Porton Pharma Solutions Ltd stock undervalued or overvalued?

Compared to the current market price of 25.86 CNY, Porton Pharma Solutions Ltd is Overvalued by 28%.

Back to Top